ABVC
ABVC BioPharma·NASDAQ
--
--(--)
--
--(--)
ABVC Filings
Filing Date
Form Description
Form Type
2026-02-05
Form PRE 14A - Other preliminary proxy statements
Key Events
2026-02-05 · Key Events
Form PRE 14A - Other preliminary proxy statements
2026-01-16
Form 8-K/A - Current report: [Amend]
Key Events
2026-01-16 · Key Events
Form 8-K/A - Current report: [Amend]
2025-11-14
Form 424B4 - Prospectus [Rule 424(b)(4)]
2025-11-14 ·
Form 424B4 - Prospectus [Rule 424(b)(4)]
2025-11-14
Form 424B4 - Prospectus [Rule 424(b)(4)]
2025-11-14 ·
Form 424B4 - Prospectus [Rule 424(b)(4)]
2025-11-14
Form 424B4 - Prospectus [Rule 424(b)(4)]
2025-11-14 ·
Form 424B4 - Prospectus [Rule 424(b)(4)]
2025-11-14
Form 424B4 - Prospectus [Rule 424(b)(4)]
2025-11-14 ·
Form 424B4 - Prospectus [Rule 424(b)(4)]
2025-11-03
Form 8-K - Current report
Key Events
2025-11-03 · Key Events
Form 8-K - Current report
2025-11-03
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-03 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-10-30
Form 8-K - Current report
Key Events
2025-10-30 · Key Events
Form 8-K - Current report
2025-09-12
Form 8-K/A - Current report: [Amend]
Key Events
2025-09-12 · Key Events
Form 8-K/A - Current report: [Amend]
